Ticker

A peer-reviewed pilot study at a Canadian critical care centre marks the first deployment of nasal photodisinfection in an intensive care setting. Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF) shares rose 8% to 11.85p after the company announced a peer-reviewed publication of a pilot study showing its Steriwave nasal photodisinfection therapy reduced pneumonia rates by 39.5% in intensive care unit patients.

ICU Medical is positioned for margin expansion as Smiths Medical integration and remediation costs subside, with upcoming product launches supporting growth. ICUI is gaining share in infusion pumps and consumables, leveraging product differentiation and rebounding from past compliance issues. Management targets net debt/EBITDA below 2.0x, opening the door for increased capital returns via buybacks or dividends…

Auna (NYSE: AUNA - Get Free Report) and SeaStar Medical (NASDAQ: ICU - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, risk and institutional ownership. Analyst Ratings This is a breakdown of current

Results from pediatric patients in the SAVE Registry shows no device-related adverse events or immunosuppression and continued strong survival data

Added top-rated children's hospitals to QUELIMMUNE™ pediatric Acute Kidney Injury (AKI) customer base Completed enrollment in FDA-mandated QUELIMMUNE SAVE Post-Marketing Registry Exceeded 50% enrollment milestone in pivotal trial of SCD therapy in adult patients with AKI Advanced pipeline indications with initiation of cardio-renal clinical trial Webcast today at 4:30 pm Eastern Time DENVER, March 25, 2026 (GLOBE…